• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直接和间接映射评估生命质量 - 6 维度(AQoL-6D)到 EQ-5D-5L 效用,使用来自马来西亚慢性心力衰竭患者的多中心、横断面研究的数据。

Direct and Indirect Mapping of Assessment of Quality of Life - 6 Dimensions (AQoL-6D) Onto EQ-5D-5L Utilities Using Data From a Multicenter, Cross-Sectional Study of Malaysians With Chronic Heart Failure.

机构信息

Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia; Seri Manjung Hospital, Ministry of Health Malaysia, Seri Manjung, Malaysia.

Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.

出版信息

Value Health. 2024 Dec;27(12):1762-1770. doi: 10.1016/j.jval.2024.07.016. Epub 2024 Aug 9.

DOI:10.1016/j.jval.2024.07.016
PMID:39127252
Abstract

OBJECTIVES

The Assessment of Quality of Life - 6 Dimensions (AQoL-6D), a generic preference-based measure, is an appealing alternative to EQ-5D-5L for assessing health status in patients with chronic heart failure (HF), given its expanded scope. However, without a Malaysian value set, the AQoL-6D cannot generate health state utility values (HSUVs) to support local economic evaluations. This study intended to develop algorithms for predicting EQ-5D-5L HSUVs from AQoL-6D in an HF population.

METHODS

Cross-sectional data from a multicenter cohort of 419 HF outpatients were used. Both direct and indirect mapping approaches were attempted using 5 sets of explanatory variables and 8 models (ordinary least squares, Tobit, censored least absolute deviations, generalized linear model, 2-part model [TPM], beta regression-based model, adjusted limited dependent variable mixture model, and multinomial ordinal regression [MLOGIT]). The models' predictive performance was assessed through 10-fold cross-validated mean absolute error [MAE] and root mean squared error [RMSE]). Potential prediction bias was also examined graphically. The best-performing models, with the lowest RMSE and no bias, were then identified.

RESULTS

Among the models evaluated, TPM, which included age, sex, and 5 AQoL-6D dimension scores as predictors, appears to be the best-performing model for directly predicting EQ-5D-5L HSUVs from AQoL-6D. TPM yielded the lowest MAE (0.0802) and RMSE (0.1116), and demonstrated predictive accuracy for HSUVs >0.2 without significant bias. A MLOGIT model developed for response mapping had suboptimal predictive accuracy.

CONCLUSIONS

This study developed potentially useful mapping algorithms for generating Malaysian EQ-5D-5L HSUVs from AQoL-6D responses among patients with HF when direct EQ-5D-5L data are unavailable.

摘要

目的

生活质量评估-6 维度(AQoL-6D)是一种通用的偏好量表,与 EQ-5D-5L 相比,它在评估慢性心力衰竭(HF)患者的健康状况时具有更广泛的范围,因此是一种有吸引力的替代方法。然而,由于缺乏马来西亚价值体系,AQoL-6D 无法生成健康状态效用值(HSUVs),无法支持当地的经济评估。本研究旨在为 HF 人群开发从 AQoL-6D 预测 EQ-5D-5L HSUV 的算法。

方法

使用来自多中心队列的 419 名 HF 门诊患者的横断面数据。尝试使用 5 组解释变量和 8 种模型(普通最小二乘法、Tobit、截尾最小绝对偏差、广义线性模型、两部分模型[TPM]、基于贝塔回归的模型、调整受限因变量混合模型和多项有序回归[MLOGIT])进行直接和间接映射。通过 10 倍交叉验证平均绝对误差[MAE]和均方根误差[RMSE]评估模型的预测性能。还通过图形检查潜在的预测偏差。然后确定具有最低 RMSE 和无偏差的表现最佳的模型。

结果

在所评估的模型中,包含年龄、性别和 5 个 AQoL-6D 维度得分作为预测因子的 TPM 似乎是从 AQoL-6D 直接预测 EQ-5D-5L HSUV 的表现最佳模型。TPM 产生的 MAE(0.0802)和 RMSE(0.1116)最低,并且对于 HSUVs>0.2 具有预测准确性,没有明显的偏差。为响应映射开发的 MLOGIT 模型预测准确性较差。

结论

当无法直接获得 EQ-5D-5L 数据时,本研究为 HF 患者从 AQoL-6D 反应生成马来西亚 EQ-5D-5L HSUV 开发了潜在有用的映射算法。

相似文献

1
Direct and Indirect Mapping of Assessment of Quality of Life - 6 Dimensions (AQoL-6D) Onto EQ-5D-5L Utilities Using Data From a Multicenter, Cross-Sectional Study of Malaysians With Chronic Heart Failure.直接和间接映射评估生命质量 - 6 维度(AQoL-6D)到 EQ-5D-5L 效用,使用来自马来西亚慢性心力衰竭患者的多中心、横断面研究的数据。
Value Health. 2024 Dec;27(12):1762-1770. doi: 10.1016/j.jval.2024.07.016. Epub 2024 Aug 9.
2
Translation, cross-cultural adaptation, and psychometric validation of the Malay version of the Assessment of Quality of Life-6 Dimensions (Malay-AQoL-6D) instrument among Malaysians living with chronic heart failure.马来版生活质量评估-6 维度问卷(Malay-AQoL-6D)在马来西亚慢性心力衰竭患者中的翻译、跨文化调适及心理计量学验证。
J Patient Rep Outcomes. 2024 Jul 25;8(1):79. doi: 10.1186/s41687-024-00763-3.
3
Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.基于 BASDAI 和 BASFI 生成 EQ-5D-5L 健康效用评分:使用英国纵向登记数据的中轴型脊柱关节炎患者的映射研究。
Eur J Health Econ. 2022 Nov;23(8):1357-1369. doi: 10.1007/s10198-022-01429-x. Epub 2022 Feb 3.
4
Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country.在发展中国家的结直肠癌和乳腺癌患者中,将 QLQ-C30 映射到 EQ-5D-5L 和 SF-6D-V2。
Value Health Reg Issues. 2021 May;24:57-66. doi: 10.1016/j.vhri.2020.06.006. Epub 2021 Jan 25.
5
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis.开发映射算法,以根据强直性脊柱炎患者的巴斯强直性脊柱炎疾病活动指数和巴斯强直性脊柱炎功能指数预测EQ-5D健康效用值。
Health Qual Life Outcomes. 2024 Aug 7;22(1):61. doi: 10.1186/s12955-024-02276-5.
6
Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.测试替代回归模型以预测效用值:将 QLQ-C30 映射到 EQ-5D-5L 和 SF-6D 上。
Qual Life Res. 2018 Nov;27(11):2823-2839. doi: 10.1007/s11136-018-1981-6. Epub 2018 Sep 1.
7
Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.将 ALSFRS-R 和 ALSUI 与运动神经元病患者的 EQ-5D 进行映射。
Value Health. 2018 Nov;21(11):1322-1329. doi: 10.1016/j.jval.2018.05.005. Epub 2018 Jul 26.
8
Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores.将 EORTC QLQ-BR53 中文版映射到 EQ-5D-5L 和 SF-6D 效用评分上。
Patient. 2020 Oct;13(5):537-555. doi: 10.1007/s40271-020-00422-x.
9
Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.癌症特异性 EORTC QLQ-C30 量表与 EQ-5D-5L 效用评分的间接和直接映射。
Appl Health Econ Health Policy. 2022 Jan;20(1):119-131. doi: 10.1007/s40258-021-00682-0. Epub 2021 Sep 23.
10
Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients.将癌症患者专用的 QLQ-C30 量表映射到通用的 EQ-5D-5L 和 SF-6D 量表上。
Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):89-96. doi: 10.1080/14737167.2018.1517046. Epub 2018 Sep 3.

引用本文的文献

1
Development of mapping algorithms for gastric cancer: translating EORTC QLQ-C30 and QLQ-STO22 to EQ-5D-5L health utilities.胃癌映射算法的开发:将欧洲癌症研究与治疗组织QLQ-C30和QLQ-STO22转化为EQ-5D-5L健康效用值。
Qual Life Res. 2025 Sep 13. doi: 10.1007/s11136-025-04063-1.
2
Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methods.运用机器学习和传统回归方法将欧洲癌症研究与治疗组织核心生活质量问卷(EORTC QLQ-C30)及肺癌模块问卷(QLQ-LC13)映射到肺癌患者的SF-6D效用指数。
Health Qual Life Outcomes. 2025 Jul 1;23(1):66. doi: 10.1186/s12955-025-02394-8.
3
Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese patients with type 2 diabetes mellitus.
在中国2型糖尿病患者中,将糖尿病患者生活质量评估量表(ADDQoL)映射到欧洲五维健康量表(EQ-5D-5L)和简明健康效用指数6D第2版(SF-6Dv2)。
Health Qual Life Outcomes. 2025 Apr 30;23(1):46. doi: 10.1186/s12955-025-02371-1.